Atlas Trials

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Clinical trial NCT03317119 · COMPLETED

Trial details

NCT number
NCT03317119
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colon CarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal CarcinomaRAS Family Gene MutationStage III Colon Cancer AJCC v7Stage III Colorectal Cancer AJCC v7Stage III Rectal Cancer AJCC v7Stage IIIA Colon Cancer AJCC v7Stage IIIA Colorectal Cancer AJCC v7Stage IIIA Rectal Cancer AJCC v7Stage IIIB Colon Cancer AJCC v7Stage IIIB Colorectal Cancer AJCC v7
Start date
2018-04-11
Primary completion
2023-07-14
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.